# ddx_myocarditis.json â€” DB ì „ì²´ ê²€í†  í”„ë ˆì„ì›Œí¬ (v2)

> Updated after `sars_cov2_positive` ì œê±° + `recent_covid_infection` í¡ìˆ˜ ì™„ë£Œ

## 1. DB ì„¤ê³„ ì›ì¹™

### 1.1 DBì˜ ì—­í• 
- **Stage 3B (Code)**: `extraction_keywords`ë¡œ DDx candidate ë§¤ì¹­, `negative_keywords`ë¡œ false positive ì°¨ë‹¨
- **Stage 3C (LLM)**: `differentiation_guide`ë¥¼ ì°¸ì¡°í•˜ì—¬ plausibility íŒì • (none/low/moderate/high)
- **Stage 3D (Code)**: `weight`ë¡œ NCI ì ìˆ˜ ê³„ì‚° â†’ `classify()`ì˜ ì…ë ¥ê°’ ê²°ì •

**DBê°€ ê³§ ì„ìƒ íŒë‹¨ ê¸°ì¤€ì„ ** â€” keywordì— ì—†ìœ¼ë©´ ë§¤ì¹­ ì•ˆ ë˜ê³ , guideì— ì—†ìœ¼ë©´ LLMì´ ì˜ëª» íŒë‹¨í•˜ê³ , weightê°€ í‹€ë¦¬ë©´ ë¶„ë¥˜ê°€ ë°”ë€œ.

### 1.2 Weight ì„¤ê³„ ì›ì¹™
| Tier | Weight ë²”ìœ„ | ì˜ë¯¸ | classify() ì˜í–¥ |
|------|-----------|------|----------------|
| Confirmatory | 0.9-1.0 | ì¡°ì§ê²€ì‚¬ ë“± í™•ì§„ ì†Œê²¬ | ë‹¨ë…ìœ¼ë¡œ C (â‰¥0.7) |
| High | 0.6-0.8 | ë³‘ì¸ íŠ¹ì´ì  í•µì‹¬ ì†Œê²¬ | ë‹¨ë…ìœ¼ë¡œ C ê°€ëŠ¥ (â‰¥0.7) ë˜ëŠ” B2 (â‰¥0.4) |
| Medium | 0.3-0.5 | ê°ë³„ ë³´ì¡° ì†Œê²¬ | ë‹¨ë…ìœ¼ë¡œ B2 ê°€ëŠ¥ (â‰¥0.4), ì¡°í•© ì‹œ C |
| Low | 0.1-0.2 | ë¹„íŠ¹ì´ì  ì§€ì§€ ì†Œê²¬ | ë‹¨ë… ì˜í–¥ ì—†ìŒ, ì¡°í•© ì‹œ B2 ê°€ëŠ¥ |
| Zero | 0.0 | ìœ„í—˜ì¸ì (audit trailìš©) | NCI ê¸°ì—¬ ì—†ìŒ |

**í•µì‹¬ ì›ì¹™**: weightëŠ” "ì´ ì†Œê²¬ì´ ì¡´ì¬í•  ë•Œ, ëŒ€ì•ˆ ë³‘ì¸(ë°±ì‹  ì™¸)ì˜ ê°€ëŠ¥ì„±ì´ ì–¼ë§ˆë‚˜ ë†’ì•„ì§€ëŠ”ê°€"ë¥¼ ë°˜ì˜. ë°±ì‹  ì‹¬ê·¼ì—¼ì—ì„œë„ í”íˆ ë‚˜íƒ€ë‚˜ëŠ” ì†Œê²¬ì€ ë‚®ì€ weight. Stage 3Cì˜ plausibility íŒì •ì´ ìµœì¢… NCIì— ë°˜ì˜ë˜ë¯€ë¡œ, weightëŠ” "ë§Œì•½ ì´ ë§ˆì»¤ê°€ ì§„ì§œë¼ë©´"ì˜ ìµœëŒ€ NCI ê¸°ì—¬ë„ë¥¼ ì˜ë¯¸.

### 1.3 Marker ì¹´í…Œê³ ë¦¬ êµ¬ì¡°
- **primary_indicators**: í•´ë‹¹ subtypeì„ ì§ì ‘ ì‹œì‚¬í•˜ëŠ” ì†Œê²¬
- **supporting_indicators**: ë‹¨ë…ìœ¼ë¡œëŠ” ì•½í•˜ì§€ë§Œ primaryì™€ í•¨ê»˜ ì˜ë¯¸ ìˆëŠ” ì†Œê²¬
- **confirmatory**: í™•ì§„ ê²€ì‚¬ (biopsy, catheterization ë“±)

### 1.4 Keyword ì„¤ê³„ ì›ì¹™
- **extraction_keywords**: VAERS narrativeì— ë‚˜íƒ€ë‚  ìˆ˜ ìˆëŠ” ì„ìƒ ìš©ì–´ (sensitivity ìš°ì„ )
- **negative_keywords**: false positive ì°¨ë‹¨ ë¶€ì • í‘œí˜„ (ìµœì†Œ 3ê°œ ê¶Œì¥)
- **differentiation_guide**: Stage 3C LLMì˜ plausibility íŒë‹¨ ê¸°ì¤€. "ì´ ì†Œê²¬ì´ ë°±ì‹  ì‹¬ê·¼ì—¼ vs ëŒ€ì•ˆ ë³‘ì¸ ì¤‘ ì–´ëŠ ìª½ì„ ë” ì‹œì‚¬í•˜ëŠ”ê°€"ì— ì´ˆì . ì‹œê°„ì  ê°œì—°ì„±, ì„ìƒ ë§¥ë½ ë“± íŒë‹¨ ì¡°ê±´ì„ ëª…ì‹œ.

### 1.5 ë§ˆì»¤ í†µí•© ì›ì¹™ (v4.1bì—ì„œ í™•ë¦½)
ê°™ì€ ì„ìƒ í˜„ìƒì˜ ë‹¤ë¥¸ ì„œìˆ  ë°©ì‹ì´ ë‹¤ë¥¸ NCI ê²°ê³¼ë¥¼ ë‚³ìœ¼ë©´ ì•ˆ ëœë‹¤. ë™ì¼í•œ ì„ìƒì  ì˜ë¯¸ë¥¼ ê°€ì§„ ë§ˆì»¤ëŠ” í•˜ë‚˜ë¡œ í†µí•©í•˜ë˜, `differentiation_guide`ì—ì„œ ì„¸ë¶„í™”ëœ íŒë‹¨ ê¸°ì¤€(ì‹œê°„ì  ê°œì—°ì„±, ì¤‘ì¦ë„ ë“±)ì„ ì œê³µí•˜ì—¬ Stage 3C LLMì´ plausibilityë¥¼ ì°¨ë“± íŒì •í•˜ë„ë¡ í•œë‹¤.

---

## 2. í˜„ì¬ ìƒíƒœ (v4.1b, 34 markers)

### í•´ê²°ëœ ì´ìŠˆ
- ~~ğŸ”´ Issue 1: `active_covid19` â†” `sars_cov2_positive` í‚¤ì›Œë“œ ì¤‘ë³µ~~ â†’ `sars_cov2_positive` ì œê±°, `active_covid19`ì— í¡ìˆ˜
- ~~ğŸŸ¡ Issue 2: `viral_etiology.positive_viral_pcr` â†” `covid19_related.sars_cov2_positive` í‚¤ì›Œë“œ ì¤‘ë³µ~~ â†’ ë§ˆì»¤ ì œê±°ë¡œ í•´ê²°
- ~~`recent_covid_infection` ì„œìˆ  ë°©ì‹ì— ë”°ë¥¸ NCI ë³€ë™~~ â†’ `active_covid19`ì— í¡ìˆ˜, guideì— ì‹œê°„ì  ê°œì—°ì„± ê¸°ë°˜ íŒë‹¨ í†µí•©

### ë‚¨ì€ ì´ìŠˆ
| # | ì‹¬ê°ë„ | ë‚´ìš© | ì˜í–¥ |
|---|--------|------|------|
| 3 | ğŸŸ¡ | `concurrent_myositis` neg_kw 2ê°œ | false positive ë¦¬ìŠ¤í¬ ë‚®ìŒ (ICI ë§¥ë½ í•„ìš”) |
| 4 | ğŸŸ¢ | `elevated_d_dimer` neg_kw 2ê°œ | false positive ë¦¬ìŠ¤í¬ ë‚®ìŒ (low weight 0.2) |
| 5 | â¬œ | NCI ì§‘ê³„ ë¡œì§ (max vs sum) ë¯¸í™•ì¸ | Stage 3D ì½”ë“œ í™•ì¸ í•„ìš” |

### Cross-subtype keyword overlap: **0ê±´** âœ…
### Intra-subtype keyword overlap: **0ê±´** âœ…

---

## 3. Subtypeë³„ ê²€í†  ì²´í¬ë¦¬ìŠ¤íŠ¸

### A. ë§ˆì»¤ ì»¤ë²„ë¦¬ì§€
- [ ] í•´ë‹¹ ë³‘ì¸ì˜ ì£¼ìš” ì„ìƒ ì†Œê²¬ì´ ëª¨ë‘ í¬í•¨ë˜ì–´ ìˆëŠ”ê°€?
- [ ] ëˆ„ë½ëœ ê°ë³„ ì†Œê²¬ì€ ì—†ëŠ”ê°€?
- [ ] VAERS narrativeì—ì„œ í”íˆ ë‚˜íƒ€ë‚˜ëŠ” í‘œí˜„ì´ keywordsì— í¬í•¨ë˜ì–´ ìˆëŠ”ê°€?

### B. Weight ì ì •ì„±
- [ ] ë‹¨ë… C trigger (â‰¥0.7) ë§ˆì»¤ê°€ ì •ë§ í™•ì§„ê¸‰ ì†Œê²¬ì¸ê°€?
- [ ] ë‹¨ë… B2 trigger (â‰¥0.4) ë§ˆì»¤ê°€ ì •ë§ ê°ë³„ í•„ìš” ì†Œê²¬ì¸ê°€?
- [ ] ë°±ì‹  ì‹¬ê·¼ì—¼ì—ì„œë„ í”í•œ ì†Œê²¬ì´ ë†’ì€ weightë¥¼ ë°›ê³  ìˆì§€ ì•Šì€ê°€?

### C. Differentiation Guide í’ˆì§ˆ
- [ ] "ë°±ì‹  ì‹¬ê·¼ì—¼ vs ì´ ëŒ€ì•ˆ ë³‘ì¸"ì˜ ê°ë³„ í¬ì¸íŠ¸ê°€ ëª…í™•í•œê°€?
- [ ] ì‹œê°„ì  ê°œì—°ì„±, ì¤‘ì¦ë„ ë“± íŒë‹¨ ì¡°ê±´ì´ êµ¬ì²´ì ìœ¼ë¡œ ëª…ì‹œë˜ì–´ ìˆëŠ”ê°€?
- [ ] LLMì´ ì˜¤í•´í•  ìˆ˜ ìˆëŠ” ëª¨í˜¸í•œ í‘œí˜„ì´ ì—†ëŠ”ê°€?

### D. Keyword/Negative í’ˆì§ˆ
- [ ] extraction_keywords â‰¥ 5ê°œ (ì¶©ë¶„í•œ sensitivity)
- [ ] negative_keywords â‰¥ 3ê°œ (ê¶Œì¥)
- [ ] ë‹¤ë¥¸ subtype/ë§ˆì»¤ì™€ keyword ì¤‘ë³µ ì—†ìŒ

### E. ì„ìƒ ì •í™•ì„±
- [ ] pathophysiology ì„¤ëª…ì´ í˜„ì¬ ì˜í•™ ì§€ì‹ê³¼ ì¼ì¹˜í•˜ëŠ”ê°€?
- [ ] high_suspicion_criteriaê°€ ì‹¤ì œ ì„ìƒ ê¸°ì¤€ê³¼ ë¶€í•©í•˜ëŠ”ê°€?

---

## 4. Subtypeë³„ í˜„ì¬ êµ¬ì¡° + ê²€í†  ìƒíƒœ

### 4.1 viral_etiology (6 markers) â€” â¬œ ë¯¸ê²€í† 

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | positive_viral_pcr | 0.80 | 15 | 7 | 221ch |
| PRI | lymphocytosis | 0.15 | 5 | 4 | 220ch |
| SUP | fever_reported | 0.20 | 12 | 3 | 275ch |
| SUP | uri_symptoms | 0.20 | 11 | 3 | 172ch |
| SUP | gi_symptoms | 0.20 | 8 | 4 | 210ch |
| SUP | myalgia_arthralgia | 0.15 | 6 | 4 | 294ch |

**ê²€í†  í¬ì¸íŠ¸:**
- `positive_viral_pcr` (w=0.8): ë‹¨ë… C trigger. COVID ê²°ê³¼ëŠ” neg_kwì— "covid"ë¡œ ì°¨ë‹¨ ì¤‘ â€” ì¶©ë¶„í•œê°€?
- supporting markers (fever, URI, GI, myalgia)ëŠ” ëª¨ë‘ **ë°±ì‹  reactogenicity**ì™€ ê²¹ì¹  ìˆ˜ ìˆìŒ â€” guideì—ì„œ êµ¬ë¶„ì´ ëª…í™•í•œê°€?
- ëˆ„ë½ ê°€ëŠ¥: specific viral serology (paired titers), viral cardiotropism markers

### 4.2 giant_cell_myocarditis (5 markers) â€” âœ… ê²€í†  ì™„ë£Œ (v4.1a-patch1)

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | rapid_heart_failure | 0.60 | 13 | 5 | 444ch |
| PRI | high_degree_av_block | 0.50 | 10 | 13 | 619ch |
| PRI | ventricular_arrhythmia | 0.50 | 14 | 7 | 327ch |
| PRI | cardiogenic_shock | 0.40 | 15 | 3 | 219ch |
| CONF | giant_cells_on_biopsy | 1.00 | 6 | 4 | 174ch |

**Status:** patch1ì—ì„œ `high_degree_av_block` severity ë¶„ë¦¬, negative_keywords 13ê°œë¡œ ê°•í™”. ê²€ì¦ ì™„ë£Œ.

### 4.3 eosinophilic_myocarditis (4 markers) â€” â¬œ ë¯¸ê²€í† 

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | peripheral_eosinophilia | 0.70 | 6 | 3 | 225ch |
| PRI | new_medication_history | 0.30 | 12 | 3 | 246ch |
| SUP | hypersensitivity_rash | 0.20 | 11 | 3 | 204ch |
| CONF | eosinophils_on_biopsy | 1.00 | 5 | 3 | 114ch |

**ê²€í†  í¬ì¸íŠ¸:**
- `peripheral_eosinophilia` (w=0.7): ë‹¨ë… C trigger â€” ì ì ˆí•œê°€? í˜¸ì‚°êµ¬ ì¦ê°€ ìì²´ê°€ í™•ì§„ê¸‰ì¸ê°€?
- `new_medication_history` kwì— vaccine ìì²´ê°€ í¬í•¨ë˜ì§€ ì•Šë„ë¡ í™•ì¸ í•„ìš”
- ëˆ„ë½ ê°€ëŠ¥: parasitic infection markers (travel history, eosinophilia + parasite)

### 4.4 toxin_ici_myocarditis (5 markers) â€” âœ… ê²€í†  ì™„ë£Œ (v4.1a-patch1)

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | ici_therapy_active | 0.80 | 15 | 3 | 277ch |
| PRI | concurrent_myositis | 0.50 | 6 | **2** | 199ch |
| PRI | conduction_delay | 0.40 | 10 | 8 | 988ch |
| SUP | new_chemotherapy | 0.40 | 12 | 3 | 261ch |
| SUP | elevated_ck | 0.30 | 6 | 3 | 247ch |

**Status:** patch1ì—ì„œ `conduction_delay` TWO MANDATORY requirements ê°•í™”. `concurrent_myositis` neg_kw 2ê°œ â€” ë³´ê°• ê¶Œì¥.

### 4.5 ischemic_heart_disease (6 markers) â€” â¬œ ë¯¸ê²€í† 

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | prior_cad_history | 0.70 | 13 | 5 | 271ch |
| PRI | focal_st_changes | 0.50 | 10 | 8 | 525ch |
| SUP | age_over_50 | 0.00 | 16 | 4 | 219ch |
| SUP | diabetes_hypertension | 0.00 | 9 | 3 | 196ch |
| SUP | smoking_history | 0.00 | 6 | 3 | 80ch |
| CONF | positive_catheterization | 1.00 | 18 | 7 | 800ch |

**ê²€í†  í¬ì¸íŠ¸:**
- `prior_cad_history` (w=0.7): ë‹¨ë… C trigger â€” CAD ì´ë ¥ë§Œìœ¼ë¡œ í˜„ì¬ ì‹¬ê·¼ì—¼ì˜ ëŒ€ì•ˆ ì›ì¸ìœ¼ë¡œ ë³¼ ìˆ˜ ìˆëŠ”ê°€? ê¸°ì¡´ CAD í™˜ìë„ ë°±ì‹  ì‹¬ê·¼ì—¼ ë°œìƒ ê°€ëŠ¥
- `positive_catheterization`ì— SCADê°€ í¬í•¨ë¨ â€” SCADëŠ” CADì™€ ë³„ê°œ pathophysiology. ë³„ë„ ë§ˆì»¤ ë˜ëŠ” ë³„ë„ subtype í•„ìš”?
- `age_over_50` kw: "age 5"ê°€ "age 50-59"ë¥¼ ì¡ìœ¼ë ¤ëŠ” ê²ƒì´ë‚˜, "age 5" (5ì„¸)ë„ ë§¤ì¹­ë  ìœ„í—˜

### 4.6 covid19_related (4 markers) â€” ğŸŸ¡ ë¶€ë¶„ ê²€í† 

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | active_covid19 | 0.80 | 23 | 12 | 1326ch |
| PRI | mis_c_criteria_met | 0.60 | 5 | 3 | 689ch |
| PRI | mis_a_criteria_met | 0.60 | 4 | 3 | 215ch |
| SUP | elevated_d_dimer | 0.20 | 5 | **2** | 227ch |

**Status:** `active_covid19` í†µí•© ì™„ë£Œ (sars_cov2_positive + recent_covid_infection í¡ìˆ˜). ì‹œê°„ì  ê°œì—°ì„± guide êµ¬í˜„. `elevated_d_dimer` neg_kw 2ê°œ â€” ë³´ê°• ê¶Œì¥.

### 4.7 autoimmune_inflammatory (4 markers) â€” â¬œ ë¯¸ê²€í† 

| Cat | Finding | Weight | kw | neg | guide |
|-----|---------|--------|-----|-----|-------|
| PRI | known_autoimmune_dx | 0.70 | 22 | 3 | 322ch |
| PRI | positive_ana_dsdna | 0.50 | 10 | 4 | 285ch |
| SUP | systemic_inflammation | 0.30 | 11 | 4 | 362ch |
| CONF | granulomas_on_biopsy | 0.90 | 6 | 3 | 193ch |

**ê²€í†  í¬ì¸íŠ¸:**
- `known_autoimmune_dx` (w=0.7): ë‹¨ë… C trigger â€” ìê°€ë©´ì—­ ì§ˆí™˜ ì´ë ¥ë§Œìœ¼ë¡œ í˜„ì¬ ì‹¬ê·¼ì—¼ì˜ ëŒ€ì•ˆ ì›ì¸ì´ ë˜ëŠ”ê°€? ìê°€ë©´ì—­ í™˜ìë„ ë°±ì‹  ì‹¬ê·¼ì—¼ ë°œìƒ ê°€ëŠ¥
- `systemic_inflammation`: CRP/ESR ìƒìŠ¹ì€ ë°±ì‹  ì‹¬ê·¼ì—¼ì—ì„œë„ í”í•¨ â€” guideì—ì„œ ìˆ˜ì¤€ êµ¬ë¶„ì´ ìˆëŠ”ê°€?
- ëˆ„ë½ ê°€ëŠ¥: cardiac sarcoidosis markers (ë³„ë„ subtype?)

---

## 5. ë‹¨ë… C Trigger (w â‰¥ 0.7) ì„ìƒ ì ì •ì„± ê²€í† 

ì´ ë§ˆì»¤ë“¤ì€ Stage 3Cì—ì„œ plausibility=highë¥¼ ë°›ìœ¼ë©´ **ë‹¨ë…ìœ¼ë¡œ NCI â‰¥ 0.7 â†’ classify()ì—ì„œ C**ê°€ ë  ìˆ˜ ìˆë‹¤.

| Subtype | Marker | Weight | ë‹¨ë… C ì ì ˆ? | ë¹„ê³  |
|---------|--------|--------|-------------|------|
| viral | positive_viral_pcr | 0.8 | âœ… | í™•ì¸ëœ ë°”ì´ëŸ¬ìŠ¤ ê°ì—¼ = ê°•ë ¥í•œ ëŒ€ì•ˆ ì›ì¸ |
| eosinophilic | peripheral_eosinophilia | 0.7 | âš ï¸ ê²€í†  | í˜¸ì‚°êµ¬ ì¦ê°€ë§Œìœ¼ë¡œ í™•ì§„ê¸‰? ì•½ì œ ìœ ë°œ ê°€ëŠ¥ |
| toxin_ici | ici_therapy_active | 0.8 | âœ… | ICI ì¹˜ë£Œ ì¤‘ ì‹¬ê·¼ì—¼ = ê°•ë ¥í•œ ëŒ€ì•ˆ ì›ì¸ |
| ischemic | prior_cad_history | 0.7 | âš ï¸ ê²€í†  | CAD ì´ë ¥ë§Œìœ¼ë¡œëŠ” í˜„ì¬ event ì›ì¸ ë¶ˆí™•ì‹¤ |
| covid19 | active_covid19 | 0.8 | âœ… | í•˜ì§€ë§Œ guideì˜ plausibilityë¡œ ê±¸ëŸ¬ì§ |
| autoimmune | known_autoimmune_dx | 0.7 | âš ï¸ ê²€í†  | ìê°€ë©´ì—­ ì´ë ¥ë§Œìœ¼ë¡œëŠ” í˜„ì¬ event ì›ì¸ ë¶ˆí™•ì‹¤ |

**âš ï¸ 3ê°œ ë§ˆì»¤ëŠ” v4.1b 100-case ê²°ê³¼ì—ì„œ ì‹¤ì œ C ë¶„ë¥˜ì— ê¸°ì—¬í•˜ëŠ”ì§€ í™•ì¸ í•„ìš”**

---

## 6. ê²€í†  ìš°ì„ ìˆœìœ„

1. **Stage 3D NCI ì§‘ê³„ ë¡œì§ í™•ì¸** â€” max vs sum ì—¬ë¶€ê°€ ëª¨ë“  weight ì ì •ì„± íŒë‹¨ì˜ ì „ì œ
2. **ë‹¨ë… C trigger 3ê°œ** (`peripheral_eosinophilia`, `prior_cad_history`, `known_autoimmune_dx`) weight ì ì •ì„±
3. **viral_etiology** â€” reactogenicity êµ¬ë¶„, ëˆ„ë½ ë§ˆì»¤
4. **ischemic_heart_disease** â€” `age_over_50` kw ë¬¸ì œ, SCAD ì²˜ë¦¬
5. **eosinophilic / autoimmune** â€” ë“œë¬¸ ì¼€ì´ìŠ¤, 100-case ê²°ê³¼ ê¸°ë°˜
6. **minor fixes** â€” neg_kw ë¶€ì¡± 2ê±´ (`concurrent_myositis`, `elevated_d_dimer`)

---

## 7. í›„ì† ì‘ì—…

- [ ] Stage 3D NCI ì§‘ê³„ ë¡œì§ í™•ì¸ (ì½”ë“œ ë¦¬ë·°)
- [ ] v4.1b 100-case ê²°ê³¼ì—ì„œ subtypeë³„ ë§¤ì¹­ ë¹ˆë„ + NCI ê¸°ì—¬ ë¶„ì„
- [ ] ë‹¨ë… C trigger weight ì ì •ì„± í™•ì •
- [ ] ë¯¸ê²€í†  subtype ìˆœì°¨ ê²€í†  (viral â†’ ischemic â†’ eosinophilic â†’ autoimmune)
- [ ] minor neg_kw ë³´ê°•
- [ ] ì™„ì„±ëœ ì„¤ê³„ ì›ì¹™ì„ `knowledge/README.md`ë¡œ ë¬¸ì„œí™”
